A 5-channel phased array surface coil was used to acquire an ECG-gated cardiac magnetic resonance protocol inclusive of cine imaging, T1/T2 mapping, and late gadolinium enhancement. Cardiac magnetic resonance images were analyzed in Circle cvi42 v5.16 (Circle Cardiovascular Imaging, Calgary, Canada) for deriving indexed LV volumes and mass, and EF. T1 and T2 maps were analyzed with the Philips IntelliSpace software Version 11.1 (Koninklijke Philips N.V., Amsterdam, the Netherlands). The myocardial extracellular volume fraction was calculated for the whole left ventricle. Analysis of all cardiac magnetic resonance and spectroscopy was performed on anonymized data at the end of the study and blinded to the pre/post-chemotherapy status of the participants.
Circle cvi42 v5
Manufactured by Circle Cardiovascular Imaging
Sourced in Canada
Circle cvi42 v5.16 is a software suite designed for the analysis and visualization of cardiovascular magnetic resonance (CMR) images. It provides tools for segmentation, quantification, and reporting of various cardiac parameters.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using circle cvi42 v5
1
Cardiac MRI Characterization Protocol
2
Cardiac MRI Characterization Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
A 5-channel phased array surface coil was used to acquire an ECG-gated cardiac magnetic resonance protocol inclusive of cine imaging, T1/T2 mapping, and late gadolinium enhancement. Cardiac magnetic resonance images were analyzed in Circle cvi42 v5.16 (Circle Cardiovascular Imaging, Calgary, Canada) for deriving indexed LV volumes and mass, and EF. T1 and T2 maps were analyzed with the Philips IntelliSpace software Version 11.1 (Koninklijke Philips N.V., Amsterdam, the Netherlands). The myocardial extracellular volume fraction was calculated for the whole left ventricle. Analysis of all cardiac magnetic resonance and spectroscopy was performed on anonymized data at the end of the study and blinded to the pre/post-chemotherapy status of the participants.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!